MIT Jameel Clinic and Sanofi join forces to advance research in artificial intelligence and health
Within the collaboration, we will work together to progress the development of AI and ML capabilities to revolutionize healthcare and advance impactful, effective drug discovery.
Photo: Sanofi trispecific monoclonal antibody (Tri-mAb). Courtesy of Yu Qiu, Principal Scientist, Biologics Research, Sanofi R&D.
The Abdul Latif Jameel Clinic for Machine Learning in Health at MIT has reached a historic milestone that marks the first step in a long-term strategic collaboration with Sanofi, a multinational diversified healthcare company. The Jameel Clinic and Sanofi pharmaceutical research teams will collaborate on the development and application of artificial intelligence (AI) and machine learning capabilities to revolutionize healthcare and advance impactful and effective drug discovery and development.